Publications or Presentations

Pharmaceutical Commercial Forecasting: Distilling Insights from Primary Research

Gautam Aggarwal, Barrett Rankin, Andrew Lin, May 2017

Opening Moves: An Early View on Nine Aspects of the Emerging Gene Editing Market

Ben Bonifant, Sarah Jims, September 2016

The U.S. Biosimilar Market: Do Analysts Have It wrong?

Barrett Rankin, Gautam Aggarwal, Alex Sherman, Rachel Clare, September 2016

Closer to the Mark: Focusing on the Market Environment to Improve Pharmaceutical Revenue Forecasting

Ben Bonifant and Parker Guse, 2015

Should Enthusiasm Surrounding Antibiotics Be Tempered?

Chris Apolito, Kate Kitsopoulos, Ryan Coe, and Megan Thomas, 2015

Essential Steps to Successful Biopharma Partnering

Aggarwal, G (Written in Partnership with ShareVault), October 2015

Lessons From The First Biosimilar MAb Launch In Europe

Brenda Sandburg, In Vivo, October 2014 (Triangle Insights provided insights and quoted in article)

Recognizing Patterns of Competition in Mechanistically Informed Markets

Bonifant, B and Aggarwal, G., In Vivo, October 2013

Economic and Policy Trends that will Impact Dealmaking in 2014

Bonifant, B (with Daniel Adams, Protein Sciences; David Nash Thomas Jefferson University; and Dennis Purcell, Aisling Capital) September 2013

Can Isis Remain A Platform Company?

Michael Goodman, In Vivo, September 2013

Fashion or Innovation: What can We learn from Outcomes of Major Deal Trends of the Past Decade?

Ben Bonifant (with Roger Longman, Real Endpoints; Barbara Yanni, Merck; Pete Garrambone, Torreya Partners; and AJ Aralihalli, Shionogi) June 2013

Test and Learn: Making Confident Decisions on the Commercial Side

Bonifant, B and Setrakian, S., Pharmaceutical Executive, March 2013

"Triangle Insights Group is distinguished by critical thinking, analytical prowess and integrity."

- Triangle Insights

Group Client